ResMed (RMD)
(Delayed Data from NYSE)
$218.06 USD
+34.64 (18.89%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $218.00 -0.06 (-0.03%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | 1.99 |
EPS Last Quarter | 2.13 |
Last EPS Surprise | 10.94% |
ABR | 1.68 |
Earnings ESP
|
3.49% |
---|---|
Current Year | 7.40 |
Next Year | 8.40 |
EPS (TTM) | 7.25 |
P/E (F1) | 29.47 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.21B | 1.18B | 4.66B | 4.95B |
# of Estimates | 7 | 5 | 7 | 7 |
High Estimate | 1.24B | 1.20B | 4.69B | 5.00B |
Low Estimate | 1.19B | 1.17B | 4.62B | 4.90B |
Year ago Sales | 1.12B | 1.10B | 4.22B | 4.66B |
Year over Year Growth Est. | 7.68% | 7.32% | 10.28% | 6.36% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.99 | 1.97 | 7.40 | 8.40 |
# of Estimates | 7 | 5 | 8 | 7 |
Most Recent Consensus | 1.92 | 1.94 | 7.29 | 8.04 |
High Estimate | 2.12 | 2.09 | 7.77 | 9.00 |
Low Estimate | 1.88 | 1.81 | 6.53 | 7.74 |
Year ago EPS | 1.60 | 1.64 | 6.44 | 7.40 |
Year over Year Growth Est. | 24.38% | 20.12% | 14.91% | 13.49% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 2 | 3 |
Up Last 30 Days | 1 | 3 | 3 | 5 |
Up Last 60 Days | 1 | 2 | 3 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 0 |
Down Last 60 Days | 1 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Current | 1.99 | 1.97 | 7.40 | 8.40 |
7 Days Ago | 1.97 | 1.95 | 7.32 | 8.22 |
30 Days Ago | 1.97 | 1.94 | 7.32 | 8.15 |
60 Days Ago | 1.97 | 1.95 | 7.32 | 8.15 |
90 Days Ago | 1.96 | 1.93 | 7.25 | 8.12 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.06 | 2.04 | 7.58 | 8.59 |
Zacks Consensus Estimate | 1.99 | 1.97 | 7.40 | 8.40 |
Earnings ESP | 3.49% | 3.45% | 2.45% | 2.25% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.13 | 1.88 | 1.64 | 1.60 | NA |
Estimate | 1.92 | 1.81 | 1.63 | 1.67 | NA |
Difference | 0.21 | 0.07 | 0.01 | -0.07 | 0.06 |
Surprise | 10.94% | 3.87% | 0.61% | -4.19% | 2.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more